NEW MECHANISMS OF OSTEOPOROSIS FORMATION IN CASE OF TERMINAL LUNG DISEASE
Abstract
About the Authors
E. A. KochetkovaRussian Federation
L. G. Ugay
Russian Federation
Yu. V. Maystrovskaya
Russian Federation
V. A. Nevzorova
Russian Federation
N. .. Frossard
Russian Federation
J. .. Massard
Russian Federation
References
1. Бурцева Е.В., Невзорова В.А., Дюйзен И.В., Коцюрбий Е.А. Локализация рецепторов к лептину и адипонектину в коже и мышечной ткани при питательной недостаточности у пациентов ХОБЛ // Бюллетень Сибирского отделения РАМН. 2012. № 2. С. 54-58.
2. Bon J.M., Zhang Yi., Duncan S.R. et al. Plasma inflammatory mediators associated with bone metabolism in COPD // COPD. 2010. No. 7. С. 186-191.
3. Calikoglu M., Sahin G., Unlu A. et al. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters // Respiration. 2004. Vol. 71, No. 1. P. 45-50.
4. Cirmanova V., Bayer M., Starka L., Zajickova K. The effect of leptin on bone - an envolving concept of action // Physiological Research. 2008. No. 57. P. 143-151.
5. Coin A., Sergi G., Marin S. et al. Predictors of low bone mineral density in elderly males with chronic obstructive pulmonary disease: the role of body mass index // Aging Male. 2010. Vol. 13, No. 2. P. 142-147.
6. Forli L., Mellbye O.J., Halse J. et al. Cytokines, bone turnover markers and weight change in candidates for lung transplantation // Pulmonary Pharmacology and Therapeutics. 2008. No. 21. P. 188-195.
7. Hamrick M.W., Pennington C., Newton D. et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine // Bone. 2004. Vol. 34, No. 3. P. 376-383.
8. Magni P., Dozio E., Galliera E. et al. Osteoporosis and inflammation // Curr. Mol. Med. 2010. No. 10. P. 522-532.
9. Oh K.W., Lee W.Y., Rhee E.J. et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-ages men // Clin. Endocrinol. 2005. Vol. 63, No. 2. P. 131-138.
10. Olesen P., Ledet T., Rasmussen L.M. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-α // Diabetologia. 2005. No. 48. P. 561-568.
11. Orens J.B., Estenne M., Arcasoy S. et al. International guidelines for the selection of lung transplant candidates: 2006 Update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplant // J. Heart Lung Transplaant. 2006. Vol. 25. P. 745-856.
12. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity // Nature Revies Immunology. 2006. Vol. 6, No. 10. P. 772-783.
13. Shane E., Silverberg S.J., Donovan D. et al. Osteoporosis in lung transplantation candidates with end stage pulmonary disease // Am. J. Med. 1996. No. 101. P. 262-269.
14. Vondracek S.F., Voelkel N.F., McDermott M.T., Valdez C. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease // Int. J. Chron. Obstruct. Pulmon. Dis. 2009. No. 4. P. 267-277.
15. Wu N., Wang Q.-P., Li H. et al. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and biochemical markers in Chinese women // Clinica Chimica Acta. 2010. Vol. 411. P. 771-775.
Review
For citations:
Kochetkova E.A., Ugay L.G., Maystrovskaya Yu.V., Nevzorova V.A., Frossard N..., Massard J... NEW MECHANISMS OF OSTEOPOROSIS FORMATION IN CASE OF TERMINAL LUNG DISEASE. Pacific Medical Journal. 2013;(4):72-75. (In Russ.)